| 000 | 02843na a2200661 4500 | ||
|---|---|---|---|
| 001 | 251833 | ||
| 003 | koha_MIRAKIL | ||
| 005 | 20221103143643.0 | ||
| 008 | 181029b tu 000 0 | ||
| 020 |
_a9780199674442 _c£35,00 |
||
| 040 |
_aCY-NiCIU _btur _cCY-NiCIU _erda |
||
| 041 | _aEnglish | ||
| 082 |
_a616.07 _bC55 2017 |
||
| 245 |
_aClinical biochemistry _cEditor: Nessar Ahmed |
||
| 250 | _a2nd edition | ||
| 260 |
_aGreat Britain _bOxford University Press _c2017 |
||
| 264 | 1 |
_a: _b, _c. |
|
| 300 |
_axxiv, 646 p. _c24.5 cm |
||
| 336 |
_2rdacontent _atext _btxt |
||
| 337 |
_2rdamedia _aunmediated _bn |
||
| 338 |
_2rdacarrier _avolume _bnc |
||
| 504 | _aIncludes index (629- 646 p.) | ||
| 504 | _aIncludes glossary (605 - 627 p.) | ||
| 650 | _aKlinik biyokimya | ||
| 650 | _aClinical biochemistry | ||
| 650 | _aBiomedical science | ||
| 650 | _aBiyomedikal bilim | ||
| 700 | _aEditor: Ahmed, Nessar | ||
| 942 |
_2ddc _cBK |
||
| 505 | 1 |
_rDavid Cameron _p1 _tBiochemical Investigations and quality control |
|
| 505 | 1 |
_rTim James _p33 _tAutomation |
|
| 505 | 1 |
_rEdmund Lamb _p53 _tKidney disease |
|
| 505 | 1 |
_rJoanne Marsden _p89 _tHyperuricaemia and gout |
|
| 505 | 1 |
_rTim James _p104 _tFluid and electrolyte disorders |
|
| 505 | 1 |
_rDavid Tierney _p125 _tAcid-base disorders |
|
| 505 | 1 |
_rPaul Collinson and Amy Lloyd _p157 _tClinical Enzymology and biomarkers |
|
| 505 | 1 |
_rRay Sherwood _p173 _tLiver Function tests |
|
| 505 | 1 |
_rMike France _p190 _tAbnormalities of lipid metabolism |
|
| 505 | 1 |
_rNessar Ahmed _p225 _tDisorders of Calcium, phosphate, and magnesium homeostasis |
|
| 505 | 1 |
_rGarry McDowell _p263 _tAbnormal pituitary function |
|
| 505 | 1 |
_rGarry McDowell _p284 _tThyroid disease |
|
| 505 | 1 |
_rAllen Yates and Lan Laing _p300 _tDiabetes Mellitus and Hypoglycemia |
|
| 505 | 1 |
_rJohn Honour _p334 _tAdrenal disease |
|
| 505 | 1 |
_rlan Laing and Julie Thornton _p367 _tReproductive endocrinology |
|
| 505 | 1 |
_rPatrick Twomey and William Simpson _p397 _tBiochemical nutrition |
|
| 505 | 1 |
_rGarry McDowell and Gordon Brydon _p420 _tGastrointestinal disorders and Malabsorption |
|
| 505 | 1 |
_rGerald Maguire _p445 _tSpecific Protein Markers |
|
| 505 | 1 |
_rJoanne Adaway and Gilbert Wieringa _p477 _tCancer biochemistry and tumour markers |
|
| 505 | 1 |
_rMary Anne Preece _p502 _tInherited metabolic disorders and newborn screening |
|
| 505 | 1 |
_rRobin Whelpton, Nigel Brown, and Robert Flanagan _p534 _tTherapeutic drug monitoring |
|
| 505 | 1 |
_rGwendolen Ayers _p560 _tChemical toxicology |
|
| 505 | 1 |
_g584 _tAnswers to self-check questions |
|
| 505 | 1 |
_g590 _tAnswers to case studies |
|
| 505 | 1 |
_g599 _tAnswers to end-of -Chapter questions |
|
| 505 | 1 |
_g605 _tGlossary |
|
| 505 | 0 |
_g629 _tIndex |
|
| 999 |
_c73247 _d73247 |
||